Skip to content

Using Mobile Phone Short Message Service (SMS) Reminders to Enhance Appointment Attendance in DM Patients

Using Mobile Phone Short Message Service (SMS) Reminders to Enhance Type 2 Diabetes Mellitus Appointment Attendance in a Primary Care Clinic

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03055702
Enrollment
270
Registered
2017-02-16
Start date
2016-11-01
Completion date
2018-03-30
Last updated
2017-02-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Appointments and Schedules, Diabetes Mellitus, Type 2

Keywords

Short Message Service, appointment reminder, Attendance rate

Brief summary

A randomized controlled trial of patients with type 2 diabetes mellitus with multiple appointments into short message service group and control group. The attendance rate of these two groups of patients will be compared.

Detailed description

The main objective of this study is to evaluate the appointment attendance rate using SMS reminder of nurses and allied health appointments for diabetic patients, when compared to conventional telephone reminder and no reminder. We also aim at determine the factors associated with appointment attendance. Finally, we will also survey patients' acceptance and satisfaction to the SMS service. This is a single blind randomization study. It will be carried out in Ha Kwai Chung General Outpatient Clinic. The primary outcome of this study is to evaluate the attendance rate of each individual doctor, nurses and allied health clinic appointments for diabetic patients, as well as their overall attendance rates: 1. Diabetes Complication Screening Clinic (OPAS DMCS/RDNA) 2. Diabetes Nurse Intervention Clinic (OPAS DMIC/RDNI) 3. DM nurse group (OPAS RDNG) 4. Dietitian Counselling (OPAS DC/DG) 5. Physiotherapy (OPAS PTC/PTG) 6. Diabetes Doctor Session (OPAS RDR) 7. Retino photo Assessment (OPAS RDO) 8. Blood taking appointment (OPAS LABT) The secondary outcomes are: * Acceptance Rate of SMS Reminder Vs Telephone Reminder Vs no reminder * Factors associated with acceptance of SMS 1. Personal Parameters: Age, sex, educational level, occupation, mobile phone models, Habit of using mobile phone service 2. Disease Parameters: Number and types of comorbidity, disease control (by biochemical markers) 3. Quality of Life (by SF-6D) * Reported adverse effects of the reminder system * Chang in biochemical markers (BMI, HbA1c, LDL-c level) 6-9 months later Subjects who agreed to participate in this study will first receive a survey on the acceptance of SMS service. For those agree to receive SMS reminder, they will be randomized to: 1. an SMS remind them to come for scheduled clinic appointment 24-72 hours before, or 2. usual care with no reminder / telephone reminder.

Interventions

an SMS remind subjects to come for scheduled clinic appointment 24-72 hours before

Sponsors

Hospital Authority, Hong Kong
CollaboratorOTHER_GOV
The University of Hong Kong
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* With diagnosis of type 2 diabetes * Have more than 1 clinic services appointment under RAMP-DM programme: (e.g. blood taking, diabetic nurse individual counselling, group education, diabetic complication screening, retinal photo assessment, dietician counselling, etc)

Exclusion criteria

1. Cannot read or receive appointment schedule on mobile phone 2. Do not speak Cantonese/English or read Chinese/English 3. Mentally incapacitated 4. Pregnant Women

Design outcomes

Primary

MeasureTime frameDescription
Attendance Rate of the scheduled clinic appointmentbetween booking time and appointment time, usually within 1 weeks to 16 weeksAttendance Rate

Countries

Hong Kong

Contacts

Primary ContactMan Chi Dao, M.B.B.S.
thomasmcdao@gmail.com+85236515411

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026